The lack of effect of iRGD/CendR peptide on AFP release from cultured HepG2 cells suggests that the iRGD-induced increase in the tumour-to-blood transport of AFP is not due to an increased secretion of AFP from the HCC cells into the tumour interstitium. Here, AFP is linked to hepatocellular carcinoma.